Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

8 Biotech Stock Controversies Emerging From 'JPM15' Conference
TheStreet.com
Tue, 01/20/15 - 11:33 am
Tags:
JPMHC 2015, drug pricing, CAR-T, biotech, Gilead Sciences, immuno-oncology, Duchenne Muscular Dystrophy
FirstWord Lists – The drugs that will shape 2015
First Word Pharma
Mon, 01/19/15 - 04:14 pm
Tags:
Harvoni, Viekira Pak, Gilead Sciences, AbbVie, alirocumab, evolocumab, Amgen, Regeneron, Sanofi, Opdivo, Keytruda, Merck, Bristol-Myers Squibb, Novartis, CTL019, Zarxio, Pfizer, palbociclib, Saxenda, Trulicity, Afrezza, MannKind, Eli Lilly, Novo Nordisk, LCZ696, Toujeo, Breo Ellipta, GED-0301, Celgene, BiogenIdec
Gilead's appeal for drug patent in India could see protracted case
The Hindu
Sat, 01/17/15 - 11:05 am
Tags:
Gilead Sciences, India, hepatitis C, Sovaldi
Aetna backs Gilead's hepatitis C treatment, gets discount
Reuters
Sat, 01/17/15 - 11:03 am
Tags:
Aetna, Gilead Sciences, hepatitis C, AbbVie, Sovaldi, Harvoni, Viekira Pak
Gilead to appeal India patent ruling on hepatitis C drug
Yahoo/Reuters
Fri, 01/16/15 - 08:11 am
Tags:
Gilead Sciences, India, patents, Sovaldi, hepatitis C
Insight - Big Pharma faces up to new price pressure from aggressive insurers
Yahoo/Reuters
Thu, 01/15/15 - 09:02 am
Tags:
insurance, Big Pharma, drug pricing, Express Scripts, AbbVie, Gilead Sciences, AstraZeneca, Eli Lilly
India Rejects Gilead Patent Bid for Sovaldi Hepatitis C Treatment
WSJ Pharmalot
Thu, 01/15/15 - 08:59 am
Tags:
India, patents, Gilead Sciences, Sovaldi, hepatitis C
Aetna CEO says no decision yet on how to cover hepatitis C drugs
Yahoo/Reuters
Wed, 01/14/15 - 09:01 am
Tags:
Aetna, hepatitis C, AbbVie, Gilead Sciences
Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 1
TheStreet.com
Fri, 01/9/15 - 09:17 am
Tags:
Celgene, Gilead Sciences, Express Scripts, Biogen Idec, Amicus Therapeutics, NPS Pharmaceuticals, Sanofi, Acadia, Orexigen, Pharmacyclics, Vertex Pharmaceuticals
Is Gilead Sciences Inc. Now a Takeover Target?
Motley Fool
Fri, 01/9/15 - 08:29 am
Tags:
Gilead Sciences, M&A, Novartis, Pfizer, JNJ, Merck
Biotech’s Price Wars Are Just Beginning
Bloomberg
Fri, 01/9/15 - 08:01 am
Tags:
biotech, AbbVie, Gilead Sciences, drug pricing, hepatitis C
Anthem selects Gilead as primary supplier of hepatitis C drugs
Yahoo/Reuters
Thu, 01/8/15 - 10:21 pm
Tags:
Gilead Sciences, Anthem, hepatitis C
Gilead Sciences to liver disease treatment from Phenex for as much as $470 million
Yahoo/AP
Tue, 01/6/15 - 03:36 pm
Tags:
Gilead Sciences, Phenex, NASH, liver disease
Fifteen Fabulously Intelligent Biotech Stock Predictions for 2015
TheStreet.com
Tue, 01/6/15 - 08:52 am
Tags:
Sanofi, MannKind, Gilead Sciences, Santhera, Puma Biotechnology, Bluebird Bio, Celgene, Pfizer, Biogen Idec
CVS Picks Gilead Hep C Drugs As Price War Looms
Investors.com
Mon, 01/5/15 - 04:04 pm
Tags:
CVS, Gilead Sciences, Express Scripts, AbbVie, drug pricing, hepatitis C, Harvoni, Sovaldi
Why Gilead Sciences, Inc. Stock Plunged as Much as 14% in December
Motley Fool
Mon, 01/5/15 - 10:38 am
Tags:
Gilead Sciences, AbbVie, Harvoni, Sovaldi, Express Scripts, hepatitis C
Grading Pharma In 2014: 17 Drug Companies Ranked
Forbes
Sun, 01/4/15 - 10:23 pm
Tags:
Actavis, Celgene, Amgen, AbbVie, Gilead Sciences, Eli Lilly, Novartis, AstraZeneca, Merck, JNJ, Biogen Idec, Novo Nordisk, Roche, Bristol-Myers Squibb, Pfizer, GSK, Sanofi
Is there a balm for Gilead?
Columbia Tribune, MO
Sun, 01/4/15 - 10:16 am
Tags:
Gilead Sciences
How 1 Tiny Hepatitis C Drug Developer Trounced Gilead Sciences, Inc. in 2014
Motley Fool
Fri, 01/2/15 - 08:26 am
Tags:
hepatitis C, Gilead Sciences, Regulus, Harvoni, Sovaldi, RG-101
5 Biotech Stocks With Big News Due In January
Investors.com
Wed, 12/31/14 - 05:15 pm
Tags:
Celgene, Biogen Idec, Gilead Sciences, AbbVie, Vertex Pharmaceuticals, Bristol-Myers Squibb

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.